The Statistical Center of the International Bone Marrow Transplant Registry (IBMTR) and the Autologous Blood and Marrow Transplant Registry of North America (ABMTR) coordinates an international effort to collect and analyze data on outcome of blood and bone marrow (hematopoietic stem cell) transplants. The IBMTR, established in 1972, and the ABMTR, established in 1990, involve greater than 400 transplant centers in 47 countries. Participating centers submit data on consecutive transplants to the IBMTR/ABMTR Statistical Center. The Registries have data for greater than 65,000 transplants. These data are used for determining transplant results in specific clinical situations, identifying prognostic factors, comparing transplant regimens, comparing transplant with non-transplant therapy, assessing intercenter variability in diagnosis, practice and outcome, evaluating transplant costs and cost- effectiveness, planning clinical trials or treatment protocols, and developing approaches to evaluating transplant outcome. Statistical Center personnel have a strong record of expert and innovative analyses of these and other issues using IBMTR/ABMTR data. The proposed grant will support continued development of this unique resource of data and statistical expertise. The proposal outlines several enhancements to the Statistical Center's data collection, entry and management system, including addition of cost information, that will ensure availability of demographic, medical and financial data on a large and representative group of transplant recipients for use by the scientific community. The proposal includes several strategies to increase awareness of this resource and enhance its availability to investigators and health policy makers, including development of a public use database. The project will also develop statistical methodologies appropriate for unbiased and efficient analyses of transplant data and provide expert statistical support for studies using IBMTR/ABMTR data.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
5U24CA076518-02
Application #
2882499
Study Section
Special Emphasis Panel (ZCA1-RLB-7 (O6))
Program Officer
Wu, Roy S
Project Start
1998-03-01
Project End
2003-02-28
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Medical College of Wisconsin
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Sureda, Anna; Zhang, Mei-Jie; Dreger, Peter et al. (2018) Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR. Cancer 124:1733-1742
Kumar, S K; Dispenzieri, A; Fraser, R et al. (2018) Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time. Leukemia 32:986-995
McCurdy, Shannon R; Zhang, Mei-Jie; St Martin, Andrew et al. (2018) Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide. Blood Adv 2:299-307
Epperla, Narendranath; Ahn, Kwang Woo; Armand, Philippe et al. (2018) Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma. Biol Blood Marrow Transplant 24:78-85
Inamoto, Yoshihiro; Petri?ek, Igor; Burns, Linda et al. (2018) Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Biol Blood Marrow Transplant :
Sahebi, Firoozeh; Garderet, Laurent; Kanate, Abraham S et al. (2018) Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report. Biol Blood Marrow Transplant :
Pulsipher, Michael A; Logan, Brent R; Kiefer, Deidre M et al. (2018) Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at 1-year compared to unrelated donors. Haematologica :
Jacobsohn, David A; Loken, Michael R; Fei, Mingwei et al. (2018) Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. Biol Blood Marrow Transplant 24:2040-2046
Lund, Troy C; Ahn, Kwang Woo; Tecca, Heather R et al. (2018) Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia. Biol Blood Marrow Transplant :
Nemecek, Eneida R; Hilger, Ralf A; Adams, Alexia et al. (2018) Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood Biol Blood Marrow Transplant 24:1651-1656

Showing the most recent 10 out of 641 publications